The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. DocGo Inc shares valued at $13,300 were purchased by Burdiek Michael J on May 23 ’25. At $1.33 per share, Burdiek Michael J acquired 10,000 shares. The insider’s holdings grew to 641,560 shares worth approximately $0.89 million following the completion of this transaction.
Also, Burdiek Michael J purchased 15,000 shares, netting a total of over 21,450 in proceeds. Following the buying of shares at $1.43 each, the insider now holds 631,560 shares.
Before that, Klasko Stephen K. M.D. had added 15,000 shares to its account. In a trade valued at $22,350, the Director bought DocGo Inc shares for $1.49 each. Upon closing the transaction, the insider’s holdings increased to 15,000 shares, worth approximately $20850.0.
As published in a research note from BTIG Research on May 09, 2025, DocGo Inc [DCGO] has been rated down from a Buy to a Neutral. Analysts at Deutsche Bank downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in late February. As of August 18, 2023, BTIG Research has initiated its “Buy” rating for DCGO. Earlier on April 21, 2023, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for DCGO stock.
Analyzing DCGO Stock Performance
On last trading session, DocGo Inc [NASDAQ: DCGO] plunged -1.42% to $1.39. The stock’s lowest price that day was $1.37, but it reached a high of $1.49 in the same session. During the last five days, there has been a surge of approximately 2.21%. Over the course of the year, DocGo Inc shares have dropped approximately -55.16%.
Is DocGo Inc subject to short interest?
Stocks of DocGo Inc saw a sharp steep in short interest on 2025-07-15 dropping by -0.77 million shares to 5.25 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 6.02 million shares. A decline of -14.72% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 7.05 of the overall float, the days-to-cover ratio (short ratio) decline to 7.05.
Which companies own the most shares of DocGo Inc (DCGO)?
In terms of DocGo Inc share price expectations, FactSet research, analysts set an average price target of 2.85 in the next 12 months, up nearly 102.13% from the previous closing price of $1.41. Analysts anticipate DocGo Inc stock to reach 2.85 by 2025, with the lowest price target being 2.85. In spite of this, 2 analysts ranked DocGo Inc stock as Buy at the end of 2025. On April 19, 2022, Deutsche Bank assigned a price target of “a Buy” to the stock and initiated coverage with a $11.
